TY  - GEN
AU  - Edwards,Beatrice J
AU  - Gounder,Mrinal
AU  - McKoy,June M
AU  - Boyd,Ian
AU  - Farrugia,Mathew
AU  - Migliorati,Cesar
AU  - Marx,Robert
AU  - Ruggiero,Salvatore
AU  - Dimopoulos,Meletios
AU  - Raisch,Dennis W
AU  - Singhal,Seema
AU  - Carson,Ken
AU  - Obadina,Eniola
AU  - Trifilio,Steve
AU  - West,Dennis
AU  - Mehta,Jayesh
AU  - Bennett,Charles L
TI  - Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw
SN  - 1474-5488
PY  - 2008///1210
KW  - Administration, Oral
KW  - Adverse Drug Reaction Reporting Systems
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Bone Density Conservation Agents
KW  - adverse effects
KW  - Diphosphonates
KW  - Drug Approval
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Incidence
KW  - Infusions, Intravenous
KW  - Jaw
KW  - drug effects
KW  - Male
KW  - Osteonecrosis
KW  - chemically induced
KW  - Pamidronate
KW  - Precipitating Factors
KW  - Tooth Extraction
KW  - United States
KW  - epidemiology
KW  - United States Food and Drug Administration
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
UR  - https://doi.org/10.1016/S1470-2045(08)70305-X
ER  -